Myasthenia gravis (MG) with symptoms limited to eye muscles [ocular MG (OMG)] is a rare
disease. OMG incidence varies according to ethnicity and age of onset. In recent years, both …

Ocular myasthenia gravis (OMG) is a neuromuscular disease characterized by autoantibody
production against post-synaptic proteins in the neuromuscular junction. The …

Background It is well demonstrated that immunosuppressants can reduce, but not eliminate
the risk of generalized development in ocular myasthenia gravis (OMG). In this study, we …

Background This study aims to develop and validate a nomogram for predicting 1-and 2-
year generalization probabilities in patients with ocular myasthenia gravis (OMG). Methods …

Myasthenia gravis (MG) is an autoimmune disease of the neuromuscular junction which
affects all striated muscles, resulting in fluctuating weakness. Approaching MG as a disease …

Myasthenia gravis is an antibody-mediated autoimmune disorder of the post-synaptic
neuromuscular junction resulting in fluctuating, fatigable weakness. Most patients first …

Backgrounds and Objectives Early use of immunosuppression has been suggested to
prevent generalization of ocular myasthenia gravis (OMG), but high-quality evidence is …

Introduction Many patients with ocular myasthenia gravis (OMG) progress to generalized
disease within the first 2 years of the onset of ocular symptoms. Several retrospective studies …

Background To analyze disease generalization in patients with ocular myasthenia gravis
(OMG) treated with immunosuppression compared with patients without …

Our understanding of OMG and its variable phenotypes continues to evolve. Autoantibody
testing increasingly provides valuable diagnostic and prognostic information. Despite these …